SEC Form 4 · accession 0001225208-16-028089
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 10:51 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2016 | A | 3,171 | $59.64 | A | 30,666 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.